A rejuvenation roundup for January 2026 has been reported. However, the specifics of the roundup are unclear, as some outlets appear to be referencing roundups from previous years or different topics, such as geroscience and cellular reprogramming. It is also mentioned that Life Biosciences has announced FDA clearance of an investigational new drug, but its connection to the rejuvenation roundup is not specified.